Overall, given that the prevailing hypothesis of disrupted monoamine neurotransmitters acts as a key contributor to the pathophysiology of depression, the current literature strongly suggests that the overactivation of the LHb, concurrent with the inhibition of monoaminergic systems, may, therefore, play a significant role in the pathogenesis of depressive disorders. This evidence concerns the gene LHB and depressive symptom measurement.